1. Home
  2. Live Updates
  3. Frank holz

Live Breaking News & Updates on Frank holz

Stay informed with the latest breaking news from Frank holz on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Frank holz and stay connected to the pulse of your community

Aviceda Therapeutics Announces Formation of Renowned European Clinical Advisory Board

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 8, 2024--

London , City-of , United-kingdom , Germany , Tel-aviv , Israel , Austria , Vienna , Wien , Cambridge , Cambridgeshire , United-states

Rare Eye Disease Gets New Monitoring Option

Rare Eye Disease Gets New Monitoring Option
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Mannheim , Baden-wüberg , Germany , Bonn , Nordrhein-westfalen , Janh-terheyden , Matthias-schmid , Frank-holz , Frankg-holz , Moritz-berger , Nicholasr-merten , Maximilian-wm-wintergerst

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMDStudy confirms subretinal prothesis feasible and well-tolerated with no r...

London , City-of , United-kingdom , France , Paris , France-general- , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Stanford-university , California , United-states

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024 38 patients

Germany , Paris , France-general- , France , Netherlands , United-kingdom , Stanford-university , California , United-states , Italy , Moorfields , Ballymena

Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering

Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paris , France-general- , France , Stanford-university , California , United-states , Moorfields , Ballymena , United-kingdom , Bonn , Nordrhein-westfalen , Germany

Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022

Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022 The target number of 38 patients have

Germany , Paris , France-general- , France , Netherlands , United-kingdom , Stanford-university , California , United-states , Italy , Moorfields , Ballymena

Investegate |Pixium Vision Announcements | Pixium Vision: Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022

Investegate announcements from Pixium Vision, Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022

Germany , Paris , France-general- , France , Netherlands , United-kingdom , Stanford-university , California , United-states , Italy , Moorfields , Ballymena

Uveitis in Eyes: How swelling and irritation occur? Know about the new diagnostic method

Blurred vision, floaters and unusual light perception – those affected by the rare disease posterior uveitis feel no pain.

Bern , Switzerland , Bonn , Nordrhein-westfalen , Germany , Maximilian-wintergerst , Frank-holz , University-hospital-of-ophthalmology , Ophthalmology-department , University-of-bonn-department-ophthalmology , University-of-bonn , University-hospital-bonn

Novel method for accurate diagnosis and treatment of uveitis

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and the need for immunosuppressive therapy.

Germany , Bern , Switzerland , Bonn , Nordrhein-westfalen , Maximilian-wintergerst , Frank-holz , Emily-henderson , University-hospital-of-ophthalmology , Ophthalmology-department , University-of-bonn , University-hospital-bonn

Researchers discover new diagnostic method for posterior uveitis eye disease

Uveitis, a rare inflammatory eye illness, is responsible for five to ten percent of blindness worldwide. In particular, posterior uveitis is frequently associat

Germany , Bern , Switzerland , Bonn , Nordrhein-westfalen , Maximilian-wintergerst , Frank-holz , University-hospital-of-ophthalmology , Ophthalmology-department , University-of-bonn-department-ophthalmology , University-of-bonn , University-hospital-bonn